BD announces leadership changes
This article was originally published in Clinica
Executive Summary
Becton Dickinson (Franklin Lakes, New Jersey) has promoted Vincent Forlenza to president, effective from January 2009; and David Elkins is named as executive vice-president and CFO, effective from December 1 2008. Former president Edward Ludwig will remain as CEO and chairman; former executive vice-president Gary Cohen, and former CFO John Considine will join the Office of the CEO – a special strategic group for the CEO. Mr Considine will continue to be responsible for: integrated supply chain; IT; environment; health and safety; project management and engineering services; and security. Mr Forlenza, who has been with the company since 1980, most recently as executive vice-president and the head of BD Diagnostics, will oversee the medical, diagnostics and biosciences divisions, international and quality operations. Mr Elkins will be responsible for executive management and oversight of the company’s global financial operations. He joins from AstraZeneca, where in 2006 he became vice-president and CFO for North America and global marketing.
You may also be interested in...
Asia Regulatory Forum Update
Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System.
Saudi Arabia adopts interim device authorisation regulation
Saudi Arabia has adopted an interim marketing authorisation regulation under which, possibly as early as 2010, only medical devices that have been approved by the Saudi Arabia Food and Drug Administration will be allowed on the market1. Additionally, only medical devices that comply with the regulations in force in the European Union, the US, Canada, Japan or Australia – ie in the jurisdiction of a Global Harmonization Task Force founding member - will be eligible for marketing in the country2,3.
Canada takes action to increase more adverse event reporting
The government of Canada has launched a marketing campaign to encourage consumers and healthcare professionals to use the country’s MedEffect initiative for reporting suspected adverse events related to healthcare products1.